Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Butylamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 8/20 | 0.53 |
| ▸ | TSHR | P16473 | 3/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.53 |
| ▸ | GABBR2 | O75899 | 2/20 | 0.48 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.48 |
| ▸ | GABBR1 | Q9UBS5 | 2/20 | 0.48 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.48 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.48 |
| ▸ | GABRP | O00591 | 1/20 | 0.48 |
| ▸ | GABRD | O14764 | 1/20 | 0.48 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.48 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.48 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Butylamine SCHEMBL3530621 | 1.00 | DNM1 (0.53) | DNM1TSHRKMT2AALDH1A1MEN1 | |
| Butylamine SCHEMBL2547783 | 1.00 | — | — | |
| Butylamine SCHEMBL10776957 | 0.94 | DNM1 (0.48) | DNM1TSHRKMT2AALDH1A1MEN1 | |
| Butylamine SCHEMBL28387748 | 0.91 | DNM1 (0.50) | DNM1TSHRKMT2AALDH1A1MEN1 | |
| Oxalic Acid SCHEMBL15753036 | 0.91 | ALOX15 (0.54) | DNM1TSHRKMT2AALDH1A1MEN1 | |
| Butylamine SCHEMBL7710328 | 0.91 | DNM1 (0.50) | DNM1TSHRKMT2AALDH1A1MEN1 | |
| Oxalic Acid SCHEMBL9480406 | 0.91 | ALOX15 (0.54) | DNM1TSHRKMT2AALDH1A1MEN1 | |
| Butylamine SCHEMBL27548898 | 0.91 | — | — | |
| Butylamine SCHEMBL384189 | 0.91 | — | — | |
| Butylamine SCHEMBL27717338 | 0.91 | DNM1 (0.50) | DNM1TSHRKMT2AALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12501540-B2 | Electronic device and manufacturing method thereof | FUJIFILM CORPORATION (JP) | 2025-12-16 | — | — | US | disclosed |
| US-12451440-B2 | Electronic device and manufacturing method thereof | FUJIFILM CORPORATION (JP) | 2025-10-21 | — | — | US | disclosed |
| US-12389549-B2 | Manufacturing method of electronic device | FUJIFILM CORPORATION (JP) | 2025-08-12 | — | — | US | disclosed |
| US-20250236954-A1 | MANUFACTURING METHOD OF CONDUCTIVE FILM AND MANUFACTURING METHOD OF ELECTROMAGNETIC WAVE SHIELDING BODY | FUJIFILM CORPORATION (JP) | 2025-07-24 | — | — | US | disclosed |
| CN-119866391-A | Method for producing conductive film and method for producing electromagnetic wave shield | 富士胶片株式会社 | 2025-04-22 | — | — | CN | disclosed |
| US-20240424817-A1 | MANUFACTURING METHOD OF CONDUCTOR, MANUFACTURING METHOD OF ELECTROMAGNETIC WAVE SHIELDING BODY, AND CONDUCTOR | FUJIFILM CORPORATION (JP) | 2024-12-26 | — | — | US | disclosed |
| US-20240425715-A1 | MANUFACTURING METHOD OF CONDUCTIVE LAYER | FUJIFILM CORPORATION (JP) | 2024-12-26 | — | — | US | disclosed |
| US-20240414839-A1 | MANUFACTURING METHOD OF PRINTED CIRCUIT BOARD | FUJIFILM CORPORATION (JP) | 2024-12-12 | — | — | US | disclosed |
| CN-118900778-A | Method for manufacturing conductive layer | 富士胶片株式会社 | 2024-11-05 | — | — | CN | disclosed |
| CN-118900729-A | Method for manufacturing electric conductor, method for manufacturing electromagnetic wave shield, and electric conductor | 富士胶片株式会社 | 2024-11-05 | — | — | CN | disclosed |
| US-20140271932-A1 | RODENTICIDAL COMPOSITION AND METHOD | PIC CORPORATION | 2014-09-18 | — | — | US | disclosed |
| EP-2125715-A2 | PROCESS FOR THE PREPARATION OF EZETIMIBE AND DERIVATIVES THEREOF | KRKA (SI) | 2009-12-02 | — | — | EP | disclosed |
| EP-2094664-A2 | A NEW PROCESS FOR THE PREPARATION OF MONTELUKAST | KRKA, tovarna zdravil, d.d., Novo mesto (SI) | 2009-09-02 | — | — | EP | disclosed |
| WO-2008089984-A2 | PROCESS FOR THE PREPARATION OF EZETIMIBE AND DERIVATIVES THEREOF | KRKA (SI) | 2008-07-31 | — | — | WO | disclosed |
| WO-2008049922-A2 | A NEW PROCESS FOR THE PREPARATION OF MONTELUKAST | KRKA, TOVARNA ZDRAVIL, D.D., NOVO MESTO (SI) | 2008-05-02 | — | — | WO | disclosed |
| EP-1121378-A1 | A PROCESS FOR THE PREPARATION OF A THROMBUS IMAGING AGENT | Du Pont Pharmaceuticals Company (US) | 2001-08-08 | — | — | EP | disclosed |
| WO-2000021982-A1 | A PROCESS FOR THE PREPARATION OF A THROMBUS IMAGING AGENT | DU PONT PHARMACEUTICALS COMPANY (US) | 2000-04-20 | — | — | WO | disclosed |
| EP-0971906-A1 | LIPASE CATALYZED DYNAMIC RESOLUTION OF ISOXAZOLINE THIOESTERS TO ISOXAZOLINE CARBOXYLIC ACIDS | Du Pont Pharmaceuticals Company (US) | 2000-01-19 | — | — | EP | disclosed |
| WO-1998042687-A1 | LIPASE CATALYZED DYNAMIC RESOLUTION OF ISOXAZOLINE THIOESTERS TO ISOXAZOLINE CARBOXYLIC ACIDS | DU PONT PHARMACEUTICALS COMPANY (US) | 1998-10-01 | — | — | WO | disclosed |
| EP-0700390-A1 | INTERMEDIATES AND METHODS FOR THE SYNTHESIS OF ANTHRAPYRAZOLONE ANTICANCER AGENTS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1996-03-13 | — | — | EP | disclosed |